Drug intelligence / Profile preview

peceleganan

Development stage
Phase 2
Lead developer
Jiangsu ProteLight Pharmaceutical & Biotechnology
Modality
Peptides, Small Molecules
Administration
Topical
01

Overview

Peceleganan (PL-5) is a novel, chemically synthesized α-helical antimicrobial peptide (AMP) containing 26 amino acid residues. It is developed as a topical spray for the treatment of skin wound infections. Peceleganan acts as a cell membrane modulator, disrupting bacterial membranes and exhibiting broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria, including drug-resistant strains. Clinical trials have demonstrated that peceleganan spray is safe and has higher clinical efficacy than silver sulfadiazine in treating skin wound infections, though its bacterial clearance rate may be lower. The drug was independently developed by Jiangsu ProteLight Pharmaceutical and Biotechnology[1][2][3][5][7].

Brand names
PL-5 sprayPL5 sprayPL 5 spray
Other names
antimicrobial peptide PL-5AMP PL-5

Beyond the preview

Go deeper on peceleganan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on peceleganan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call